Use of a Palmaz stent for tracheomalacia: case report of an infant with esophageal atresia.
A male infant with congenital cardiac anomalies and esophageal atresia with tracheoesophageal fistula (EA-TEF) showed intractable respiratory symptoms after delayed primary repair of EA-TEF. Computed tomography demonstrated that the trachea was compressed by the enlarged aorta. Artificial ventilation was necessary even after aortopexy performed at 2 months of age. At 140 days of age, an expandable metallic stent (Palmaz stent) was inserted through a rigid bronchoscope into the trachea underfluoroscopic control. His respiratory status improved dramatically, and he was extubated in 18 hours. Although the follow-up period has been 9 months, the short-term result is satisfactory. The expandable metallic stent placement should be considered in patients with EA-TEF who show intractable respiratory symptoms caused by tracheomalacia.
Tazuke
Y
Y
Department of Pediatric Surgery, Osaka Medical Center and Research Institute for Maternal and Child Health, Izumi-city, Japan.
Kawahara
H
H
Yagi
M
M
Yoneda
A
A
Soh
H
H
Maeda
K
K
Yamamoto
T
T
Imura
K
K
D004933:Esophageal Atresia / Q000150:complications*; D006801:Humans; D007223:Infant; D008297:Male; D015607:Stents; D014133:Tracheal Diseases / Q000150:complications / Q000628:therapy*; D014138:Tracheoesophageal Fistula / Q000150:complications*